Radionuclide Drug Conjugates
Radiopharmaceuticals have proven to be effective agents since they can be successfully applied for both diagnostics and therapy. Radionuclide drug conjugates (RDCs) combine a radioactive compound, a tailored-targeting molecule for specific receptors enriched on diseased cells, and a linker for stable attachment, enabling more effective radiation delivery and significantly reducing side effects by attacking only cancerous cells.
WuXi AppTec has developed a comprehensive workflow for radiopharmaceutical discovery and development, from target selection and ligand ID to stability testing and in vivo efficacy and safety assessment.
Related Content
Kidney diseases are complex conditions caused by a variety of factors, including autoimmune diseases, metabolic disorders, infections, drug side effects,...
VIEW RESOURCEWomen's health care is crucial not only for the well-being of individual women but also for the health and prosperity...
VIEW RESOURCE